FDA Inspection 1267814 — Noevir U.S.A.
The FDA completed an inspection of Noevir U.S.A. on April 17, 2025 in Honolulu, HI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 17, 2025
- Fiscal Year
- 2025
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- Honolulu, HI (United States)